Achieve Life Sciences Aktie
WKN DE: A2JMW8 / ISIN: US0044682039
11.03.2025 13:28:00
|
Achieve Life Sciences Q4 Loss Widens
(RTTNews) - Achieve Life Sciences, Inc. (ACHV), a late-stage specialty pharmaceutical company, Tuesday reported net loss of $12.36 million or $0.36 per share, higher than $5.48 million or $0.26 per share loss in the same quarter a year.
As of December 31, 2024, the company's cash, cash equivalents, and marketable securities was $34.4 million.
The company also confirmed its plan to submit new drug application (NDA) for cytisinicline for the treatment of nicotine dependence, at the end of the second quarter of 2025.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Achieve Life Sciences Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |